Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026)
Cartesian Therapeutics (RNAC) reported EBITDA of -$39.2 million for Q1 2026, down 121.68% year-over-year from $180.7 million in Q1 2025, and up 57.66% quarter-over-quarter from -$92.6 million in Q4 2025.
Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of EBITDA data on file, last reported at -$39.2 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$39.2 million, down 121.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$151.8 million (down 296.32% YoY), and the FY2025 annual result was -$130.3 million, down 68.19% from the prior year.
- EBITDA advanced to -$39.2 million in Q1 2026 per RNAC's latest filing, from -$92.6 million in the prior quarter.
- Over five years, EBITDA peaked at $28.7 million in Q1 2022 and troughed at -$177.6 million in Q4 2023.
- A 5-year average of -$25.4 million and a median of -$11.4 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2024: EBITDA sank 3128.85% in 2023, then surged 221.34% in 2024.
- A 5-year view of EBITDA shows it stood at $5.9 million in 2022, then slumped by 3128.85% to -$177.6 million in 2023, then jumped by 94.22% to -$10.3 million in 2024, then slumped by 801.49% to -$92.6 million in 2025, then soared by 57.66% to -$39.2 million in 2026.
- Business Quant data shows RNAC's EBITDA at -$39.2 million in Q1 2026, -$92.6 million in Q4 2025, and -$35.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | -39.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.19 Mn |
| Dec 31, 2025 | -92.57 Mn |
| Sep 30, 2025 | -35.91 Mn |
| Jun 30, 2025 | 15.90 Mn |
| Mar 31, 2025 | -17.68 Mn |
| Dec 31, 2024 | -10.27 Mn |
| Sep 30, 2024 | -24.20 Mn |
| Jun 30, 2024 | 13.85 Mn |
| Mar 31, 2024 | -56.83 Mn |
| Dec 31, 2023 | -177.64 Mn |
| Sep 30, 2023 | -9.02 Mn |
| Jun 30, 2023 | -11.41 Mn |
| Mar 31, 2023 | -21.67 Mn |
| Dec 31, 2022 | 5.87 Mn |
| Sep 30, 2022 | -7.94 Mn |
| Jun 30, 2022 | 8.72 Mn |
| Mar 31, 2022 | 28.75 Mn |
| Dec 31, 2021 | 12.23 Mn |
| Sep 30, 2021 | -17.90 Mn |
| Jun 30, 2021 | 4.58 Mn |